Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Dec 2025 is -98.62% vs 137.70% in Dec 2024
Consolidate Net Profit
YoY Growth in quarter ended Dec 2025 is 38.14% vs 77.78% in Dec 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Dec 2025 is -92.98% vs 86.62% in Dec 2024
Interest
YoY Growth in quarter ended Dec 2025 is -94.58% vs 0.00% in Dec 2024
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Dec 2025 has fallen from Dec 2024
Compare Quarterly Results Of BioLineRx Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Dec 2025 is -57.14% vs 27.27% in Sep 2025
YoY Growth in quarter ended Dec 2025 is -98.62% vs 137.70% in Dec 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Dec 2025 is -121.21% vs 76.60% in Sep 2025
YoY Growth in quarter ended Dec 2025 is 38.14% vs 77.78% in Dec 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Dec 2025 is -57.14% vs 7.89% in Sep 2025
YoY Growth in quarter ended Dec 2025 is -92.98% vs 86.62% in Dec 2024
Quarterly - Interest
QoQ Growth in quarter ended Dec 2025 is -10.00% vs 0.00% in Sep 2025
YoY Growth in quarter ended Dec 2025 is -94.58% vs 0.00% in Dec 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Dec 2025 has fallen from Sep 2025
YoY Growth in quarter ended Dec 2025 has fallen from Dec 2024






